Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,625.00 +325.49 (+0.48%) CMC Crypto 200
1,423.59 -4.97 (-0.35%)
NVAX Jan 2026 3.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 01:05PM EDT
| Previous close | 10.73 |
| Open | 10.73 |
| Bid | 10.05 |
| Ask | 12.30 |
| Strike | 3.00 |
| Expiry date | 2026-01-16 |
| Day's range | 10.73 - 10.73 |
| Contract range | N/A |
| Volume | |
| Open interest | 11 |
PR NewswireNovavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
ZacksHere is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Barrons.comArbutus, Novavax See Activist Investor Action
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
© 2024 Yahoo. All rights reserved.